Contract

Pneumococcal conjugate vaccine (PCV) 2024

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

F03: Contract award notice

Notice identifier: 2024/S 000-005110

Procurement identifier (OCID): ocds-h6vhtk-03a759

Published 15 February 2024, 2:40pm



Section one: Contracting authority

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

10 South Colonnade

London

E14 4PU

Contact

Chantal Jockel

Email

chantal.jockel@ukhsa.gov.uk

Country

United Kingdom

Region code

UKI42 - Tower Hamlets

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Pneumococcal conjugate vaccine (PCV) 2024

Reference number

CM/PHV/24/193679

two.1.2) Main CPV code

  • 33651600 - Vaccines

two.1.3) Type of contract

Supplies

two.1.4) Short description

Contract for the supply of pneumococcal conjugate vaccine (PCV)

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Lutterworth, UK

two.2.4) Description of the procurement

A contract for a vaccine to protect against invasive Pneumococcal disease, to be used as part of the national childhood immunisation programme.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

two.2.5) Award criteria

Quality criterion - Name: Clinical benefit / Weighting: N/A

Quality criterion - Name: Adjusting for doses which are not administered to individuals / Weighting: N/A

Quality criterion - Name: Programme risk / Weighting: N/A

Quality criterion - Name: Social value / Weighting: N/A

Cost criterion - Name: Administration costs / Weighting: N/A

Cost criterion - Name: Risk mitigation costs / Weighting: N/A

Cost criterion - Name: Vaccine price / Weighting: N/A

Cost criterion - Name: Storage cost / Weighting: N/A

two.2.11) Information about options

Options: Yes

Description of options

The contract has the option to be extended for up to an additional 24 months

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Value — The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2023/S 000-021853


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

8 February 2024

five.2.2) Information about tenders

Number of tenders received: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

PFIZER LIMITED

Ramsgate Road, Sandwich

Kent

CT13 9NJ

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

00526209

Internet address

http://www.pfizer.co.uk

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1

Total value of the contract/lot: £1


Section six. Complementary information

six.3) Additional information

The contract is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.

six.4) Procedures for review

six.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

Country

United Kingdom

Internet address

https://www.judiciary.uk/courts-and-tribunals/high-court/